Patrick Couvreur

Orsay, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 154 publications

Measures to strengthen international biosafety and biosecurity practices.

Measures to strengthen international biosafety and biosecurity practices.

Journal: PLoS biology

Published: March 18, 2026

Oral solid lipid nanoparticles of etoposide enable metronomic-like therapy with reduced toxicity in MYCN-amplified neuroblastoma.

Oral solid lipid nanoparticles of etoposide enable metronomic-like therapy with reduced toxicity in MYCN-amplified neuroblastoma.

Journal: Cancer letters

Published: January 30, 2026

Combining Leu-enkephalin nanomedicines with enkephalinase inhibitors: a promising painkiller strategy?

Combining Leu-enkephalin nanomedicines with enkephalinase inhibitors: a promising painkiller strategy?

Journal: Drug delivery and translational research

Published: July 31, 2025

Squalene-adenosine nanoparticles enhance cardioprotection in myocardial infarction: Efficacy and mechanistic insights.

Squalene-adenosine nanoparticles enhance cardioprotection in myocardial infarction: Efficacy and mechanistic insights.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: July 12, 2025

Nanomedicines for the treatment of serious diseases and dual research

Nanomedicines for the treatment of serious diseases and dual research

Journal: Comptes rendus biologies

Published: September 04, 2024

A nanomedicine approach for the treatment of long-lasting pain.

A nanomedicine approach for the treatment of long-lasting pain.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: April 05, 2024

RNA-loaded nanoparticles for the treatment of hematological cancers.

RNA-loaded nanoparticles for the treatment of hematological cancers.

Journal: Advanced drug delivery reviews

Published: February 19, 2024

Assessment of Squalene-Adenosine Nanoparticles in Two Rodent Models of Cardiac Ischemia-Reperfusion.

Assessment of Squalene-Adenosine Nanoparticles in Two Rodent Models of Cardiac Ischemia-Reperfusion.

Journal: Pharmaceutics

Published: May 22, 2023

Correction: Toxicity of metal-organic framework nanoparticles: from essential analyses to potential applications.

Correction: Toxicity of metal-organic framework nanoparticles: from essential analyses to potential applications.

Journal: Chemical Society reviews

Published: January 19, 2023

Validation study for in vitro skin irritation test using reconstructed human skin equivalents constructed by layer-by-layer cell coating technology.

Validation study for in vitro skin irritation test using reconstructed human skin equivalents constructed by layer-by-layer cell coating technology.

Journal: Journal of applied toxicology : JAT

Published: October 03, 2022

Plasma membrane lipid bilayer is druggable: Selective delivery of gemcitabine-squalene nano-medicine to cancer cells.

Plasma membrane lipid bilayer is druggable: Selective delivery of gemcitabine-squalene nano-medicine to cancer cells.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: September 14, 2022

Nanomedicines and cell-based therapies for embryonal tumors of the nervous system.

Nanomedicines and cell-based therapies for embryonal tumors of the nervous system.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: April 12, 2022

Showing 1-12 of 154

Last Updated: 09/26/2026